ACRO Welcomes Nomination of Califf to Head FDA
WASHINGTON, Sept. 17, 2015 (GLOBE NEWSWIRE) -- Doug Peddicord, PhD, Executive Director of the Association of Clinical Research Organizations (ACRO), today issued the following statement regarding President Obama's nomination of Dr. Robert Califf to serve as the next Commissioner of the Food and Drug Administration:
"ACRO welcomes the nomination of Dr. Califf as FDA Commissioner. We have worked closely with Rob through the Clinical Trials Transformation Initiative and other collaborations and look forward to having a FDA Commissioner who understands and appreciates the critical role clinical research organizations play in today's drug development process. His extensive experience in clinical research and translational medicine will greatly benefit the agency and the American people as the concepts in 21st Century Cures are implemented." About ACRO
The Association of Clinical Research Organizations (ACRO) represents companies that provide a variety of specialized services that support the development of new pharmaceuticals, biologics, and medical devices. The Association provides an active voice for the CRO industry globally. Through its member companies, ACRO helps improve the quality, efficiency and safety of biomedical research. ACRO member companies employ approximately 110,000 professionals worldwide and conduct research in 142 countries. For more information, please visit www.acrohealth.org. Twitter @acrohealth. YouTube @ACROHealthChannel. Facebook, RebelMouse.
CONTACT: John Lewis
[email protected]
202.464.9340
Source: Association of Clinical Research Organizations (ACRO)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HII wins $99M Navy contract for DDG 1002 sea trials
- Best Crypto Presale: Could AlphaPepe Be the Next AI Crypto to Explode Ahead of Bittensor and NEAR Protocol?
- XRP Price Prediction: Kalshi Odds Jump to 24% as Traders Pile Into Pepeto Presale Eyeing 100x
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Twitter, Barack ObamaSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share